KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

D-Wave Quantum (QBTS) Cash & Equivalents (2020 - 2025)

D-Wave Quantum's Cash & Equivalents history spans 6 years, with the latest figure at $635.3 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 256.98% year-over-year to $635.3 million; the TTM value through Dec 2025 reached $635.3 million, up 256.98%, while the annual FY2025 figure was $635.3 million, 256.98% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $635.3 million at D-Wave Quantum, down from $836.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $836.2 million in Q3 2025 and bottomed at $8.0 million in Q3 2021.
  • The 5-year median for Cash & Equivalents is $178.0 million (2024), against an average of $316.2 million.
  • The largest annual shift saw Cash & Equivalents plummeted 55.55% in 2021 before it skyrocketed 330.87% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $9.5 million in 2021, then soared by 45.14% to $13.8 million in 2022, then surged by 200.11% to $41.3 million in 2023, then soared by 330.87% to $178.0 million in 2024, then skyrocketed by 256.98% to $635.3 million in 2025.
  • Per Business Quant, the three most recent readings for QBTS's Cash & Equivalents are $635.3 million (Q4 2025), $836.2 million (Q3 2025), and $819.3 million (Q2 2025).